Serial #90322503
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #90322503 Trademark

Serial Number: 90322503 • Registration: 7033451

Serial #90322503 is a trademark filed by Guangzhou Healthquest Pharmaceuticals Co., Ltd. on November 16, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Guangzhou Healthquest Pharmaceuticals Co., Ltd.

Room 515, Building F, No. 3, Lanyue Road
Guangdong Province 510663 , CN

Entity Type: 03

Trademark Details

Filing Date

November 16, 2020

Registration Date

April 25, 2023

Published for Opposition

February 7, 2023

Goods & Services

Medicines for dental purposes; Chemical preparations for medical purposes for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antibiotics; Injection, namely, pharmaceutical preparations in the form of injection for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Tablets, namely, pharmaceutical preparations in the form of tablet for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Bulk drugs, namely, prescription pills, tablets, capsules, caplets and pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Biochemical medicines, namely, prescription pills, tablets, capsules, caplets and pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Antiseptics; Collyrium; Laxative suppositories; Paster, namely, medicated plasters; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Medicated sweets; Candy for medical purposes; Dietetic foods adapted for medical purposes; Dietetic beverages adapted for medical purposes; Dietetic substances preparations adapted for medical use; Medicinal oils; Mineral food supplements; Nutritional supplements; Medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Pharmaceutical chemical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Radioactive substances for medical purposes; Gases for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants; Solutions for contact lenses; Media for bacteriological cultures; Depuratives for the body; Diagnostic preparations for veterinary purposes; Pesticides; Sanitary napkins; Cotton for medical purposes; Dental abrasives; Diapers for pets

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 25, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 25, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 18, 2023 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jan 4, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 30, 2022 ERRR
ELECTRONIC RECORD REVIEW COMPLETE
Dec 27, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 23, 2022 ERRR
ELECTRONIC RECORD REVIEW COMPLETE
Dec 19, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 16, 2022 ERRR
ELECTRONIC RECORD REVIEW COMPLETE
Dec 8, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 2, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2022 CRFA
ASSIGNED TO LIE
Nov 7, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 31, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 18, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 18, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
May 18, 2022 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 18, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 18, 2021 GNSL
SUSPENSION LETTER WRITTEN
Nov 18, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 26, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 26, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 26, 2021 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 2, 2021 AMPX
ASSIGNED TO LIE
Mar 1, 2021 ALIE
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 16, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 30, 2020 PARI
NEW APPLICATION ENTERED
Nov 19, 2020 NWAP